TY - JOUR T1 - Information and genetic counselling for psychiatric risks in children with rare genomic disorders JF - medRxiv DO - 10.1101/19007294 SP - 19007294 AU - Andrew Cuthbert AU - Aimee Challenger AU - Jeremy Hall AU - Marianne BM van den Bree Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/09/25/19007294.abstract N2 - Purpose Genomic medicine has transformed the diagnosis of neurodevelopmental disorders. Evidence of increased psychiatric comorbidity associated with genomic copy number and single nucleotide variants (CNV and SNV) may not be fully considered when providing genetic counselling. We explored parents’ experiences of genetics services and how they obtained information concerning psychiatric manifestations.Methods Parents of children diagnosed with genomic variants completed an online survey exploring, (i) how they experienced the genetic diagnosis, and (ii) how they acquired information about psychiatric, developmental and physical manifestations.Results Two-hundred and 86 respondents completed the survey. Thirty percent were unsatisfied with receiving genetic diagnoses. Satisfaction was predicted if communication was by geneticists (p = 0.004); provided face-to-face (p = 0.003); clearly explained (p < 0.001); and accompanied by support (p = 0.017). Parents obtained psychiatric information from non-professional sources more often than developmental (ϕ 0.26, p < 0.001) and physical manifestations (ϕ 0.21, p = 0.003), which mostly came from health professionals. Information from support organisations was more helpful than from geneticists (odds ratio [OR] 21.0, 95% CI 5.1 – 86.8, p < 0.001); paediatricians (OR 11.0, 1.4 – 85.2, p = 0.004); and internet sites (OR 15.5, 3.7 – 64.8, p < 0.001).Conclusion A paucity of professional information about psychiatric risks after genetic diagnosis may impede early diagnosis and intervention for children with high genotypic risks. Planned integration of genomic testing into mainstream services should include genetic counselling training to address the full spectrum of developmental, physical and psychiatric manifestations and timely provision of high-quality information.Competing Interest StatementThe authors have declared no competing interest.Funding StatementUK Medical Research Council - grant No. MR/N022572/1 The Waterloo Foundation - grant No. 506926Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesWill individual participant data be available? Yes What data will be shared? All of the relevant participant responses to the survey, after deidentification What other documents be available Yes, the survey questions When will the data be available? Immediately after publication With whom? Researchers who provide a reasonable request based on a methodological sound proposal For what types of analysis? To achieve the aims of their submitted proposal How will the data be made available? In response to email sent to the corresponding author (ORCID iD 0000-0002-4426-3254). A link to the survey data (after deidentification) will be provided to approved requests. Proposals may be submitted up to 36 months following the article’s publication. ER -